Welcome to our dedicated page for Rubicon Organics news (Ticker: ROMJF), a resource for investors and traders seeking the latest updates and insights on Rubicon Organics stock.
Rubicon Organics Inc. cultivates and sells certified organic, premium and super-premium cannabis products in Canada under brands including Simply Bare™ Organics, 1964 Supply Co.™, Wildflower™ and Homestead Cannabis Supply™. Company news commonly covers cultivation activity at its Pacifica hybrid greenhouse in Delta, British Columbia, and Cascadia indoor facility in Hope, British Columbia, together with product launches, brand distribution and financial results.
Updates also address GACP certification for regulated international medical cannabis markets, wholesale exports and medical cannabis distribution outside Canada, line-of-credit amendments, equity incentive grants and other corporate finance matters tied to the company’s licensed-producer operations.
Rubicon Organics (OTCQX: ROMJF), a premium cannabis producer, held its Annual General and Special Meeting with 46.3% shareholder representation. Shareholders approved all proposed matters, including setting the board size at eight directors and electing all nominated directors with approval rates ranging from 85.7% to 95.8%.
The company announced a significant leadership change as Len Boggio steps down as Board Chair, transitioning to Chair of the Nomination and Governance Committee. Doris Bitz, an independent director since 2023 with over 30 years of CPG and manufacturing experience, has been appointed as the new Board Chair.
Shareholders also approved amendments to the company's Omnibus Equity Incentive Plan with 74.7% support. The plan allows for a maximum of 8,960,180 Common Shares for equity awards. Additionally, the company granted 1,024,576 DSUs to independent directors, vesting in twelve months.
Rubicon Organics (OTCQX: ROMJF), a licensed producer of organic certified and premium cannabis, has announced its upcoming Annual General and Special Meeting scheduled for July 31, 2025, at 10:00 AM PT. The meeting will be held at the Terminal City Club in Vancouver, with a live webcast option available.
The meeting agenda includes receiving 2024 financial statements, setting the board size at eight directors, electing directors, appointing PricewaterhouseCoopers LLP as auditors, and considering an amendment to the Omnibus Equity Incentive Plan to reserve 8,960,179 Common Shares for issuance. The record date for the meeting was set for June 25, 2025.
Rubicon Organics (OTCQX: ROMJF) has announced the launch of its new 1964 Supply Co.™ All-in-One (AIO) Full Spectrum Extract (FSE) Resin Vapes in the Canadian market. The product features the Comatose strain in a 0.5 gram format and will initially launch in British Columbia before expanding to other major Canadian provinces, excluding Quebec.
The launch follows the successful introduction of 510 FSE resin vape cartridges in May 2024. The company plans to launch two additional AIO offerings by the end of 2025. The product aims to attract legacy market consumers by offering high-quality FSE resin vapes at competitive price points, distinguishing itself in a market dominated by distillate-based products.
Rubicon Organics (ROMJF) has cleared all conditions precedent for acquiring the Hope Facility from Medipharm Labs Inc. The facility is a 47,500 square foot indoor cultivation facility located in Hope, British Columbia. This strategic acquisition is expected to significantly expand Rubicon's premium cannabis production capacity.
The company, which specializes in organic certified and premium cannabis products, anticipates closing the acquisition in the second quarter. CEO Margaret Brodie emphasized that this acquisition represents a pivotal step in meeting growing demand for their premium brands, accelerating innovation, and creating long-term shareholder value.
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF), a licensed producer specializing in organic certified and premium cannabis products, has scheduled its Q1 2025 financial results announcement for Tuesday, May 27, 2025, after market close.
The company will host a conference call to discuss the results on Wednesday, May 28, 2025, at 7:00 AM PT / 10:00 AM ET. Investors can join via local dial-in (+1 (289) 514 5100) or toll-free North America (+1 (800) 717 1738) using conference ID 34244.
Rubicon Organics (ROMJF) has appointed Glen Ibbott, former CFO of Aurora Cannabis, as its Interim Chief Financial Officer, effective May 15, 2025. Ibbott replaces Janis Risbin, who will transition to an advisory role. With over 25 years of leadership experience in publicly-traded companies, Ibbott is known for his significant role at Aurora Cannabis (2017-2024), where he drove rapid growth and achieved positive EBITDA. His experience includes senior finance roles at healthcare companies and a crucial role in QLT Inc.'s $500 million merger with Aegerion Pharmaceuticals.
Ibbott, who holds dual CPA designations and MBAs from Cornell and Queen's University, joins Rubicon as the company plans to scale new capacity and explore international markets. The company has initiated a search for a permanent CFO, considering both internal and external candidates.
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF), Canada's leading premium licensed cannabis producer, has announced its participation in two major industry events in April 2025:
1. Planet MicroCap Showcase: VEGAS 2025 (April 22-24):
- Company presentation on April 23 at 11:30 AM PST
- One-on-one investor meetings with CEO Margaret Brodie on April 24
- Location: Paris Hotel & Casino, Las Vegas
2. ICBC Berlin B2B (April 29-30):
- CEO Margaret Brodie to participate in panel discussion on April 29 at 11:45 AM CET
- Panel focuses on future of cannabis B2B ecosystem
- Location: Estrel Berlin Hotel, Berlin, Germany
Rubicon Organics (ROMJF) reported strong financial results for 2024, with record-high net revenue of $48.7 million, representing a 21% increase from 2023. The company achieved an Adjusted EBITDA of $4.0 million and operating cash flow of $3.4 million.
Q4 2024 highlights include net revenue of $14.2 million (up 42% from Q4 2023), Adjusted EBITDA of $1.6 million, and positive operating cashflows of $2.3 million. The company secured $10 million in credit facilities at 6.75% interest for 5 years and entered into a purchase agreement for a Hope, BC facility that will expand premium flower capacity by 40%.
Key market positions include: 27.1% market share in topicals, 2.0% in national flower and pre-rolls, and 26.5% in premium edibles. The company's vape launch achieved 13.4% national market share with 56% distribution within six months.